Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
South Korea’s stringent reimbursement criteria for biologic treatments are preventing many severe asthma patients from accessing life-saving therapies, according to Professor Song Woo-jung of Asan Medical Center. The specialist argues that these restrictions force patients to remain dependent on systemic steroids, exposing them to serious long-term complications and exacerbating health inequalities across the country.